AiXin Life International, Inc. (AIXN) stock: key figures, P/E, revenue and dividend

Consumer Staples · China

Price
0.26 USD
Market cap
6.50 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

AiXin Life International, Inc. financials

Fiscal year2025
Revenue665,788.00 USD
Gross profit-202,033.00 USD
Operating income-2.52 m USD
EBIT-2.02 m USD
Net income-2.04 m USD
Diluted EPS – continuing operations-0.08 USD

Full history since 2010, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About AiXin Life International, Inc.

AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. It operates through Direct Sales, Pharmacy, Hotel, and Manufacture and Sale segments. The company provides herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat's milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. It also engages in hotel business. The company provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. It sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. AiXin Life International, Inc. is based in Chengdu, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.